Our Princeton office, which opened in 1987, houses lawyers who advise major national corporations and closely held businesses, particularly in the life sciences industry, on transactional matters, intellectual property issues, and on high-level litigation, including class action matters.
Product Liability and Mass Torts
Dechert is a national and international leader in product liability and mass tort defense. Our practice focuses both on helping clients avoid mass tort exposure and on defending them when litigation hits. Much of Dechert’s work involves prescription drugs and devices, biologics, chemicals, and toxic substances emissions. Our lawyers also have significant experience with consumer products and durable goods. Whatever the origin of the claim, Dechert is experienced in handling cases involving latent injuries and complex issues of medical causation.
Mergers & Acquisitions
Our M&A lawyers advise buyers, sellers, and advisers in complex commercial transactions, with a focus on structuring successful deals, ensuring speed-to-market execution, and protecting our clients’ interests in all phases of the transaction. Recognized as a leading adviser among M&A law firms by Mergerstat, Bloomberg, Thomson Financial, and mergermarket, we handle private and public, domestic and cross-border, and negotiated and hostile transactions in the Americas, Europe, and Asia. We leverage our industry knowledge and collaborate with our functional experts in areas such as antitrust, tax, environmental, bankruptcy, and employee benefits.
Dechert’s life sciences group is dedicated to providing quality, cost-effective legal services to the life sciences community. We recognize the complex business, legal, and regulatory issues that confront life sciences companies in all stages of growth. We know the challenges posed by the development and commercialization of a new technology in a highly competitive environment. We have dedicated our resources, experience, and knowledge base to serving life sciences companies located nationally and internationally. We have represented companies involved in all aspects of the life sciences industry, including biotechnology, bio-informatics, drug discovery, genomics, biopharmaceutical, diagnostic, and medical device companies.
Dechert’s international intellectual property practice focuses on litigation, counseling and transactional IP matters. We protect and defend our clients’ rights in patent, trade secret, copyright, trademark, privacy, data protection and IP-antitrust disputes in jurisdictions around the world, including the International Trade Commission. We also provide trademark and copyright counseling and prosecution services, and negotiate licensing, development, joint venture, outsourcing, consulting, and other transactions involving IP issues. In addition, we handle strategic patent counseling and patent cross-licensing to help maximize value at every stage of the life cycle of our clients’ products and patents. Comprised of lawyers who combine decades of IP experience with training in science, technology, engineering, medicine and business, our fluency in sophisticated subject matter affords our clients an advantage in the courtroom and at the negotiating table. We have been hailed as a “go-to law firm” for IP by Corporate Counsel, and our IP partners and specialty groups have received accolades from Chambers USA, Chambers UK, Legal 500, Best Lawyers in America and Benchmark Litigation.
Securities Litigation and Enforcement
Our securities litigation lawyers defend clients in complex, high-risk litigation. We represent clients in securities litigation, securities enforcement matters, corporate governance, fiduciary, mergers and acquisitions, and banking and financial institution litigation. Our clients include public and private corporations, private equity funds, officers and directors, special committees, and professional service firms. Dechert is one of a handful of national law firms with a long-standing practice in securities enforcement. Many of our lawyers have held senior positions at the U.S. Securities and Exchange Commission, U.S. Department of Justice, and other relevant agencies. Hence, when we advocate on behalf of our clients, we do so with the perspective and credibility that comes from having been in the shoes of the government decision-makers.